{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["TYR", "Wnt signaling", "combination therapy", "melanogenesis", "vitiligo"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34939426", "DateCompleted": {"Year": "2022", "Month": "03", "Day": "03"}, "DateRevised": {"Year": "2022", "Month": "03", "Day": "03"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "12", "Day": "23"}], "Language": ["eng"], "ELocationID": ["10.4155/fmc-2021-0150"], "Journal": {"ISSN": "1756-8927", "JournalIssue": {"Volume": "14", "Issue": "4", "PubDate": {"Year": "2022", "Month": "Feb"}}, "Title": "Future medicinal chemistry", "ISOAbbreviation": "Future Med Chem"}, "ArticleTitle": "Discovery of small-molecule modulators of melanogenesis by docking-based virtual screening.", "Pagination": {"StartPage": "221", "EndPage": "231", "MedlinePgn": "221-231"}, "Abstract": {"AbstractText": ["<b>Background:</b> Vitiligo is a relatively common depigmenting skin disorder. UV light stimulation is often used to obtain repigmentation. Wnt signaling regulates melanocyte differentiation, and expression of TYR is upregulated in narrow-band UVB-treated epidermis. Manipulation of these two pathways by drugs could serve as one of the therapeutic approaches for durable repigmentation. <b>Methods & results:</b> CD9 was identified as a novel TYR activator by virtual screening and bioactivity assay. CD9 activated the Wnt signaling pathway through triggering translocation of \u03b2-catenin from cytoplasm to nucleus. <b>Conclusion:</b> The pathogenesis of vitiligo is complicated and varies with each individual, so combination therapy may be much more suitable for treatment of vitiligo. CD9 could synergize with other anti-inflammatory compounds or autoimmune suppressors to shorten repigmentation time and improve efficacy."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory of Plant Resources & Chemistry of Arid Zone; State Key Laboratory Basis of Xinjiang Indigenous Medicinal Plants Resource Utilization; Xinjiang Technical Institute of Physics & Chemistry, Chinese Academy of Sciences, Urumqi, 830011, PR China."}, {"Identifier": [], "Affiliation": "University of Chinese Academy of Sciences, Beijing, 100049, PR China."}], "LastName": "Abudureyimu", "ForeName": "Miernisha", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory of Plant Resources & Chemistry of Arid Zone; State Key Laboratory Basis of Xinjiang Indigenous Medicinal Plants Resource Utilization; Xinjiang Technical Institute of Physics & Chemistry, Chinese Academy of Sciences, Urumqi, 830011, PR China."}], "LastName": "Zang", "ForeName": "Deng", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Hospital of Xinjiang Traditional Uyghur Medicine, Urumqi, 830049, PR China."}], "LastName": "Talifu", "ForeName": "Ainiwaer", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Drug Discovery & Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 211203, PR China."}], "LastName": "Zhu", "ForeName": "Weiliang", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory of Plant Resources & Chemistry of Arid Zone; State Key Laboratory Basis of Xinjiang Indigenous Medicinal Plants Resource Utilization; Xinjiang Technical Institute of Physics & Chemistry, Chinese Academy of Sciences, Urumqi, 830011, PR China."}], "LastName": "Aisa", "ForeName": "Haji Akber", "Initials": "HA"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Future Med Chem", "NlmUniqueID": "101511162", "ISSNLinking": "1756-8919"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Ligands"}, {"RegistryNumber": "0", "NameOfSubstance": "Melanins"}, {"RegistryNumber": "0", "NameOfSubstance": "Small Molecule Libraries"}, {"RegistryNumber": "0", "NameOfSubstance": "Tetraspanin 29"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Binding Sites"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Survival"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Ligands"}, {"QualifierName": ["metabolism"], "DescriptorName": "Melanins"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": ["chemistry", "metabolism", "pharmacology", "therapeutic use"], "DescriptorName": "Small Molecule Libraries"}, {"QualifierName": ["chemistry", "metabolism"], "DescriptorName": "Tetraspanin 29"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Vitiligo"}, {"QualifierName": ["drug effects"], "DescriptorName": "Wnt Signaling Pathway"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2021", "Month": "12", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "3", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "12", "Day": "23", "Hour": "8", "Minute": "39"}], "PublicationStatus": "ppublish", "ArticleIdList": ["34939426", "10.4155/fmc-2021-0150"]}}], "PubmedBookArticle": []}